Sign Out
Bortezomib for Injection is indicated as follows: Mantle Cell Lymphoma: Bortezomib is used for treatment of mantle cell lymphoma in patients who have received at least one prior therapy.
Multiple Myeloma: Previously Untreated Multiple Myeloma: Bortezomib is used in combination with melphalan and prednisone for the treatment of Previously Untreated Multiple Myeloma.
Relapse Multiple Myeloma: Bortezomib is used alone for the treatment of relapse multiple myeloma in patients who have received at least one prior therapy.
Induction Therapy Prior to Stem-cell Transplantation: Bortezomib in combination with dexamethasone is indicated for the induction treatment of patients with newly diagnosed with multiple myeloma who are to undergo an autologous stem-cell transplant.
